Anika Therapeutics, Inc.: capex
| Value | {"amount": 2543000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-03-31 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7c3ecc5a-6205-4a99-a4a5-1060a5ca002d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-18-003806Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/capex/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7c3ecc5a-6205-4a99-a4a5-1060a5ca002d
History
- no predecessors — first report